HK1140136A1 - A medicament for treating chronic obstructive pulmonary disease - Google Patents

A medicament for treating chronic obstructive pulmonary disease

Info

Publication number
HK1140136A1
HK1140136A1 HK10106278.8A HK10106278A HK1140136A1 HK 1140136 A1 HK1140136 A1 HK 1140136A1 HK 10106278 A HK10106278 A HK 10106278A HK 1140136 A1 HK1140136 A1 HK 1140136A1
Authority
HK
Hong Kong
Prior art keywords
medicament
pulmonary disease
chronic obstructive
obstructive pulmonary
treating chronic
Prior art date
Application number
HK10106278.8A
Other languages
English (en)
Inventor
Yoichi Yabuuchi
Kounori Kotosai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1140136A1 publication Critical patent/HK1140136A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK10106278.8A 2007-03-09 2010-06-25 A medicament for treating chronic obstructive pulmonary disease HK1140136A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007059664 2007-03-09
PCT/JP2008/054689 WO2008111662A1 (en) 2007-03-09 2008-03-07 A medicament for treating chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
HK1140136A1 true HK1140136A1 (en) 2010-10-08

Family

ID=39431212

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10106278.8A HK1140136A1 (en) 2007-03-09 2010-06-25 A medicament for treating chronic obstructive pulmonary disease

Country Status (20)

Country Link
US (1) US20100048621A1 (ja)
EP (1) EP2120904A1 (ja)
JP (1) JP5265580B2 (ja)
KR (1) KR101442874B1 (ja)
CN (1) CN101631538B (ja)
AR (1) AR065588A1 (ja)
AU (1) AU2008225372B2 (ja)
BR (1) BRPI0808344A2 (ja)
CA (1) CA2678920C (ja)
HK (1) HK1140136A1 (ja)
IL (1) IL200436A0 (ja)
MX (1) MX2009009634A (ja)
MY (1) MY151196A (ja)
NZ (1) NZ579186A (ja)
RU (1) RU2451507C2 (ja)
SG (1) SG179440A1 (ja)
TW (1) TWI352593B (ja)
UA (1) UA95830C2 (ja)
WO (1) WO2008111662A1 (ja)
ZA (1) ZA200905854B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108299263B (zh) 2018-01-30 2020-12-01 北京德默高科医药技术有限公司 一种普罗布考衍生物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5649378A (en) 1979-08-25 1981-05-02 Otsuka Pharmaceut Co Ltd Tetrazolylalkoxycarbostyril derivative
JP2574099B2 (ja) 1992-05-21 1997-01-22 大塚製薬株式会社 アレルギー疾患治療剤
JPH10175864A (ja) * 1996-12-16 1998-06-30 Otsuka Pharmaceut Co Ltd 慢性閉塞性肺疾患治療剤
US6852878B2 (en) * 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
WO1999024400A1 (en) * 1997-11-10 1999-05-20 Vyrex Corporation Probucol esters and uses thereof
US7323496B2 (en) * 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
ITMI20020597A1 (it) * 2002-03-22 2003-09-22 Nicox Sa Derivati del probucolo
JP4467429B2 (ja) * 2002-07-12 2010-05-26 アセロジエニクス・インコーポレイテツド 低溶解性プロブコールエステル類およびエーテル類の新規な塩形態
US7271274B2 (en) * 2004-04-20 2007-09-18 Ahterogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
ES2378896T3 (es) * 2005-09-15 2012-04-18 Otsuka Pharmaceutical Co., Ltd. Combinación de fármacos que contiene Probucol y un derivado de tetrazolilalcoxi-dihidrocarbostirilo con efectos inhibidores del superóxido

Also Published As

Publication number Publication date
TW200836734A (en) 2008-09-16
CN101631538B (zh) 2011-11-16
JP2010520872A (ja) 2010-06-17
JP5265580B2 (ja) 2013-08-14
EP2120904A1 (en) 2009-11-25
RU2009137378A (ru) 2011-04-20
KR101442874B1 (ko) 2014-09-19
CA2678920A1 (en) 2008-09-18
RU2451507C2 (ru) 2012-05-27
US20100048621A1 (en) 2010-02-25
TWI352593B (en) 2011-11-21
SG179440A1 (en) 2012-04-27
AR065588A1 (es) 2009-06-17
CN101631538A (zh) 2010-01-20
CA2678920C (en) 2013-10-29
KR20090119988A (ko) 2009-11-23
NZ579186A (en) 2011-05-27
UA95830C2 (ru) 2011-09-12
WO2008111662A1 (en) 2008-09-18
ZA200905854B (en) 2010-05-26
MX2009009634A (es) 2009-09-22
AU2008225372A1 (en) 2008-09-18
IL200436A0 (en) 2010-04-29
BRPI0808344A2 (pt) 2014-07-29
AU2008225372B2 (en) 2012-12-20
MY151196A (en) 2014-04-30

Similar Documents

Publication Publication Date Title
EP2242529A4 (en) OPERATING INSTRUMENTS FOR GENERATING PNEUMOSTOMAS AND TREATING CHRONIC-OBSTRUCTIVE LUNG DISEASE
BR112012015337A2 (pt) terapia combinada para doença pulmonar obstrutiva crônica
GB2465897B (en) Respiratory disease treatment
EP2349428A4 (en) NASAL BITS FOR A PATIENT INTERFACE
EP2164505A4 (en) TREATMENT OF CHRONIC LUNG DISEASE
GB0815696D0 (en) Dual model approach for boiler section cleanlines calculation
IL236360A0 (en) Inhalable medicine
BR112012015334A2 (pt) terapia combinada para doença pulmonar obstrutiva crônica
PL2247297T3 (pl) Działanie terapeutyczne w stanach chorobowych płuc
EP2467138A4 (en) USE OF AEROSOLIZED ANTIBIOTICS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE
EP1875915A4 (en) THERAPEUTIC AGENT FOR TREATING CHRONIC OBSTRUCTIVE RESPIRATORY DISEASE
GB0700645D0 (en) Targets for disease therapy
GB0701456D0 (en) Treatment for respiratory disease
EP2047862A4 (en) MEDICINE FOR TREATMENT OF NURSE DISEASES
HK1140136A1 (en) A medicament for treating chronic obstructive pulmonary disease
EP2210878A4 (en) THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES
TH0801001146A (th) ตัวยาสำหรับการรักษาโรคปอดอุดกั้นเรื้อรัง
GB0816025D0 (en) Medicament for the treatment of chronic obstructive pulmonary disease (COPD)
HK1098572A1 (en) Double inhalation traverse
GB0715397D0 (en) Treatment for joint disease
TWI372054B (en) A pharmaceutical composition for preventing or treating cardiovascular disease
GB0722047D0 (en) A medicament
GB0700643D0 (en) Targets for disease therapy
GB0700650D0 (en) Targets for disease therapy
GB0700654D0 (en) Targets for disease therapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160307